Search

Search Constraints

You searched for: Author/Creator Caron, Hubert

Search Results

1. A global approach to long‐term follow‐up of targeted and immune‐based therapy in childhood and adolescence. Issue 7 (16th April 2021)

2. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. (March 2019)

3. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients. (March 2020)

4. ACCELERATE – Five years accelerating cancer drug development for children and adolescents. (May 2022)

5. Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. (3rd August 2017)

6. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. (September 2020)

7. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study. Issue 1 (January 2020)

8. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Issue 10 (8th April 2022)

9. Implementation of mechanism of action biology-driven early drug development for children with cancer. (July 2016)

10. INSP-15. ITCC-P4: A sustainable platform of molecularly well-characterized PDX models of pediatric cancers for high throughputin vivo testing. (3rd June 2022)